Key Takeaways
- In 2022, global potential cocaine production reached a record 2,757 metric tons, with Colombia accounting for 1,738 tons or 63% of the total, sourced from the UNODC World Drug Report 2023.
- Colombia's coca cultivation area expanded to 230,000 hectares in 2022, a 13% increase from 2021, primarily in the Catatumbo and Cauca regions.
- Peru produced an estimated 717 metric tons of cocaine in 2022, with coca cultivation at 95,000 hectares, mainly in the Valle de los Ríos Apurímac, Ene y Mantaro (VRAEM).
- In 2022, approximately 22 million people aged 15-64 used cocaine worldwide at least once, representing 0.5% of the global population.
- US past-year cocaine use among adults aged 12+ was 2.0 million in 2021, or 0.7% prevalence rate.
- In Europe, 3.7 million young adults (15-34) reported cocaine use in the last year in 2022, 2.7% prevalence.
- US emergency department visits for cocaine involvement reached 505,000 in 2021.
- Cocaine causes 70,000-100,000 deaths globally per year from overdose and related causes, per WHO estimates.
- Chronic cocaine use leads to 20-30% reduction in dopamine transporter density in the striatum, shown in PET scans.
- Global cocaine market valued at $90-150 billion annually in 2022, with retail prices averaging $100-200 per gram in consumer countries.
- US cocaine market generates $30-50 billion yearly, with wholesale prices at $20,000-$30,000 per kg in 2022.
- Colombia's coca economy supports 500,000 direct jobs, contributing 2-3% to national GDP indirectly.
- Cocaine is a Schedule II controlled substance under US federal law since 1970, allowing limited medical use.
- In 2022, US federal sentencing for cocaine trafficking averaged 73 months, down from 97 months in 2010 due to FSA.
- EU member states classify cocaine as a Schedule I drug, with Portugal decriminalizing personal use in 2001.
In 2022, global cocaine production reached a record high, largely powered by expanded cultivation in Colombia and sustained output across key producing regions.
Economic Aspects
Economic Aspects Interpretation
Health Effects
Health Effects Interpretation
Legal & Policy
Legal & Policy Interpretation
Prevalence & Usage
Prevalence & Usage Interpretation
Production & Trafficking
Production & Trafficking Interpretation
Sources & References
- Reference 1UNODCunodc.orgVisit source
- Reference 2STATEstate.govVisit source
- Reference 3EMCDDAemcdda.europa.euVisit source
- Reference 4CBPcbp.govVisit source
- Reference 5DEAdea.govVisit source
- Reference 6INSIGHTCRIMEinsightcrime.orgVisit source
- Reference 7HOMEAFFAIRShomeaffairs.gov.auVisit source
- Reference 8BELASTINGDIENSTbelastingdienst.nlVisit source
- Reference 9NIDAnida.nih.govVisit source
- Reference 10AIHWaihw.gov.auVisit source
- Reference 11SAMHSAsamhsa.govVisit source
- Reference 12GOVgov.ukVisit source
- Reference 13CANADAcanada.caVisit source
- Reference 14CDCcdc.govVisit source
- Reference 15WHOwho.intVisit source
- Reference 16AHAJOURNALSahajournals.orgVisit source
- Reference 17NCBIncbi.nlm.nih.govVisit source
- Reference 18STROKEstroke.orgVisit source
- Reference 19RANDrand.orgVisit source
- Reference 20IMFimf.orgVisit source
- Reference 21USSCussc.govVisit source
- Reference 22JUSTICEjustice.govVisit source
- Reference 23INTERPOLinterpol.intVisit source
- Reference 24GUARDIACIVILguardiacivil.esVisit source
- Reference 25OFDTofdt.frVisit source






